|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
03.08.26 - 14:03
|
Neuronetics and Jorey Chernett Announce Shared Vision (GlobeNewswire EN)
|
|
|
MALVERN, Pa., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (“Neuronetics” or the “Company”) and Jorey Chernett, the Company's second largest shareholder and Managing Member of Pointillist Family Office, today announced that they have created a constructive framework for alignment between the Company's Board of Directors (the “Board”), management, and Mr. Chernett (the “Understanding”)....
|
|
|
31.07.26 - 23:03
|
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire EN)
|
|
|
MALVERN, Pa., July 31, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced the granting of inducement awards to five new non-executive employees as described below. In accordance with NASDAQ Listing Rule 5635(c)(4), these awards were approved by Neuronetics' Compensation Committee and made as a material inducement to their respective employment with the Company. In all cases, vesting is subject to the recipient's continued service with the Company through the applicable vesting date, and the awards are subject to the terms of the Company's 2020 Inducement Incentive Plan....
|
|
|
28.07.26 - 14:33
|
Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call (GlobeNewswire EN)
|
|
|
MALVERN, Pa., July 28, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that it plans to release second quarter 2026 financial and operating results prior to market open on Tuesday, August 11, 2026. The Company will host a conference call to review its results at 8:30 a.m. Eastern Time the same day....
|
|
|
|
|
|
|
20.07.26 - 22:09
|
Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes (GlobeNewswire EN)
|
|
|
MALVERN, Pa., July 20, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that Nir Naor will be appointed Chief Financial Officer effective July 23, 2026."Nir is a proven leader who brings the financial discipline and rigor our strategy demands," said Dan Reuvers, President and Chief Executive Officer of Neuronetics. "Across medical device and care-delivery models, he has consistently delivered profitable revenue growth and healthy cash flow while building high-performing teams and sharpening capital allocation. He is the ideal person to help us execute our strategy, expand access to our therapies, and improve the lives of the patients we serve."Naor brings more than 20 years of finance and life sciences experience. Most recently, he served as Chief Financial Officer of Axogen (NASDA...
|
|
|
|
|
06.07.26 - 14:33
|
Neuronetics to Participate in a Panel Discussion at B. Riley Securities′ Mind, Muscle & Vision Summit on July 16, 2026 (GlobeNewswire EN)
|
|
|
MALVERN, Pa., July 06, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that management will participate at the B. Riley Securities' Mind, Muscle & Vision Summit, an invitation-only institutional investor event being held in-person at the InterContinental Boston.Neuronetics will participate in a panel discussion titled "Commercializing the Next Wave of Novel Neuropsychiatric Drugs," alongside Compass Pathways, scheduled for Thursday, July 16, 2026. Management will also be available for one-on-one meetings with institutional investors throughout the day.This is an in-person, invitation-only event, and there will be no live webcast of the panel discussion.About NeuroneticsNeuronetics, Inc. is a leader in interventional mental health, combining innovative treatment technologies with direct pa...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
